LJL, Molecular Devices deal

MDCC completed its acquisition of LJLB for 4.45 million shares of MDCC stock worth $348.8 million based on MDCC's Aug. 30 closing price of $78.75 (see BioCentury, June 12). MDCC also has options and w...